HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
88.46
+5.03 (6.03%)
At close: Jun 26, 2026, 4:00 PM EDT
88.00
-0.46 (-0.52%)
After-hours: Jun 26, 2026, 6:56 PM EDT
HealthEquity Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for HealthEquity stock have an average target of 112.57, with a low estimate of 88 and a high estimate of 128. The average target predicts an increase of 27.26% from the current stock price of 88.46.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HealthEquity stock from 16 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 10 | 10 | 10 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 16 | 16 | 16 | 16 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Reiterates $123 | Buy | Reiterates | $123 | +39.05% | Jun 25, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $125 | Buy | Reiterates | $125 | +41.31% | Jun 5, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $108 | Buy | Reiterates | $108 | +22.09% | Jun 3, 2026 |
| Barclays | Barclays | Buy Reiterates $110 | Buy | Reiterates | $110 | +24.35% | Jun 3, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $110 → $111 | Buy | Maintains | $110 → $111 | +25.48% | Jun 1, 2026 |
Financial Forecast
Revenue This Year
1.42B
from 1.31B
Increased by 7.76%
Revenue Next Year
1.53B
from 1.42B
Increased by 7.92%
EPS This Year
4.73
from 4.00
Increased by 18.31%
EPS Next Year
5.49
from 4.73
Increased by 16.03%
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 1.4B | 1.6B | |
| Avg | 1.4B | 1.5B | |
| Low | 1.4B | 1.5B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 8.1% | 11.9% | |
| Avg | 7.8% | 7.9% | |
| Low | 7.3% | 4.3% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 4.93 | 6.28 | |
| Avg | 4.73 | 5.49 | |
| Low | 4.66 | 5.15 |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 23.3% | 32.7% | |
| Avg | 18.3% | 16.0% | |
| Low | 16.5% | 8.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.